Select Medical Holdings Gives Q4 Prelim. Profit Figures That Beat Estimates

Select Medical Holdings Gives Q4 Prelim. Profit Figures That Beat Estimates

Select Medical Holdings shares are lower even as it gave preliminary Q4 and full-year profit estimates that topped forecasts, with revenue in line. The company expects Q4 net income in a range of $17 million to $25 million, above estimates for $13.8 million with full-year income seen from $122 million to $130 million above estimates for $108.4 million. Full year revenue of about $4.29 billion, with Q4 revenue seen at […]

Read More ˃
Biogen and Mitsubishi Tanabe Terminate Licensing Accord

Biogen and Mitsubishi Tanabe Terminate Licensing Accord

Biogen and Mitsubishi Pharma Corp. have agreed to terminate a licence accord on MT-1303, a therapeutic agent for autoimmune diseases. Under the termination, Mitsubishi regains all development and marketing rights in the world for all indications of MT-1303 and will record a lump sum revenue, booked as liability of deferred income at the end of December 2016 based on IFRS in the 4th quarter, FY2016. The license accord dated from […]

Read More ˃
European ADRs Edge Lower

European ADRs Edge Lower

American depository receipts of European stocks were 0.2% lower at 122.99 on the Bank of New York Mellon Europe ADR Index on Friday morning. Decliners in Continental Europe were led by Swiss financial services provider Credit Suisse (CS), 3.2% lower, followed by Criteo (CRTO), a French technology company, down by 2.4% and CGG (CGG), a manufacturer of geophysical equipment, 2.3% lower. Telefonaktiebolaget (ERIC), a Sweden-based telecommunications operator, was 2.0% lower. […]

Read More ˃